Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues

Molecular and Cellular Biochemistry

Volumn 289, Issue 1-2, 2006, Pages 137-147

  Preet, Anju ^a   Siddiqui, M R ^a   Taha, A ^a   Badhai, J ^a   Hussain, M E ^b   Yadava, P K ^a   Baquer, N Z ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Diabetes; Lens; Polyol pathway; Sodium orthovanadate; Trigonella foenum graecum

Indexed keywords

ALDEHYDE REDUCTASE; ALLOXAN; FRUCTOSE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLYCOSYLATED HEMOGLOBIN; HEXOKINASE; IDITOL DEHYDROGENASE; INSULIN; MALONALDEHYDE; SORBITOL; TRIGONELLA FOENUM GRAECUM EXTRACT; VANADATE SODIUM;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LENS; LOW DRUG DOSE; MICROPHOTOGRAPHY; MITOCHONDRION SWELLING; NONHUMAN; RAT; RETINA; RETINA BIPOLAR GANGLION CELL; ROUGH ENDOPLASMIC RETICULUM; STATISTICAL SIGNIFICANCE; TRANSMISSION ELECTRON MICROSCOPY;

ALDEHYDE REDUCTASE; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HERB-DRUG INTERACTIONS; HEXOKINASE; INSULIN; L-IDITOL 2-DEHYDROGENASE; LENS, CRYSTALLINE; LIPID PEROXIDATION; PLANT EXTRACTS; RATS; RATS, WISTAR; RETINA; SORBITOL; TIME FACTORS; TRIGONELLA; VANADATES;

TRIGONELLA FOENUM-GRAECUM;

EID: 33748306020     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9156-0     Document Type: Article

References (52)

1. Ferris FL, Davis MD, Aiello LM: Treatment of diabetic retinopathy. N Engl J Med 341: 667-678, 1999
2. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001
3. Gonzalez AM, Sochor M, Hothersall JS, McLean P: Effect of experimental diabetes on the activity of hexokinase in rat lens: An example of glucose overutilization in diabetes. Biochem and Biophys Res Commun 84: 858-864, 1978
4. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, VandenEnden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813, 1993
5. Baynes JW: Role of oxidative stress in development of complications of diabetes. Diabetes 40: 405-412, 1991
6. Wolff SP: The potential role of oxidative stress in diabetes and its complications: Scientific aspects. New York: Churchill Livingstone 642-652, 1987
7. Freeman BA, CraFo JD: Biology of diseases: free radicals and tissue injury. Lab Invest 47: 412-426, 1982
8. Wohaieb SA, Godin DV: Alterations in free radicals tissue-defense mechanisms in Streptozotocin-induced diabetes in rat: Effects of insulin treatment. Diabetes Care 36: 1014-1018, 1987
9. Genet S, Kale R, Baquer NZ: Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: Effect of Vanadate and fenugreek (Trigonella foenum graecum). Mol Cell Biochem 236: 7-12, 2002
10. Chung SSM, Ho ECM, Lam KSL, Chung SK: Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14: S233-236, 2003
11. Varma SD, Schocket SS, Richards RD: Implications of aldose reductase in cataracts in human diabetes. Invest Ophthalmol Vis Sci 18: 237-241, 1979
12. Kern TS, Engerman RL: Distribution of aldose reductase in ocular tissues. Exp Eye Res 33: 175-182, 1981
13. Li QZE, Miller B, Perlman I: Early retinal damage in experimental diabetes: Electroretinographical and morphological observations. Exp Eye Res 74: 615-625, 2002
14. Lorenzi M, Gerhardinger C: Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44: 791-804, 2001
15. DCCTRG: The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
16. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
17. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ: Trigonella foenum graecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem 224: 45-51, 2001
18. Puri D, Prabhu KM, Murthy PS: Hypocholesterolemic effect of hypoglycemic principle of fenugreek (Trigonella foenum graecum) seeds. Ind J Clin Biochem 9: 13-16, 1994
19. Khosla P, Gupta DD, Nagpal RK: Effect of Trigonella foenum graecum (Fenugreek) on blood glucose in normal and diabetic rats. Indian J. Physiol. Pharmacol 39: 173-174, 1995
20. Puri D, Prabhu KM, Murthy PS: Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian J Physiol Pharmacol 46: 457-462, 2002
21. Thakran S, Salimuddin, Baquer N: Oral administration of orthovanadate and Trigonella foenum graecum seed powder restores the activities of mitochondrial enzymes in tissues of alloxan-induced diabetes. Mol Cell Biochem 247: 45-53, 2003
22. Brichard SM, Okitolonda W, Henquin JC: Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123: 2048-2053, 1988
23. Sochor M, Baquer NZ, McLean P: Effect of aldose reductase inhibiter sorbinil on metabolites in diabetic lens. Biochem pharmacol 37: 3349-3356, 1988
24. Saxena AK, Srivastava P, Kale RK, Baquer NZ: Impaired antioxidant status in diabetic rat liver: Effect of vanadate. Biochem Pharmacol 45: 539-542, 1993
25. Kinoshita JH, Futterman S, Satoh K, Marola LO: Factors affecting the formation of sugar alcohols in ocular lens. Biochem Biophys Acta 74: 340-350, 1963
26. Gerlach U, Hiby W: Assay of sorbitol. In: Methods of Enzymatic Analysis. Academic Press New York Vol 2, 569-573, 1974
27. Gumma K, McLean P: The kinetic quantitation of ATP. D-glucose-6-phosphotransferase. FEBS Lett 27: 293-297, 1972
28. Baquer NZ, Gupta D, Raju J: Regulation of metabolic pathways in liver and kidney during experimental diabetes: Effects of antidiabetic compounds. Ind J Clin Biochem 13: 63-80, 1998
29. Lawrence RA, Burk RF: Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun 71: 952-958, 1976
30. Erden M, Bor NM: Changes in reduced glutathione, glutathione reductase and glutathione peroxidase after radiation in guinea pigs. Biochem Med 31: 217-227, 1984
31. Bergmeyer HU, Bernt E, Schmidt F, Stork H: Assay for hexoses: Academic Press, New York Vol 3, 1196-1201, 1974
32. Malone JI, KnAx G, Benford S, Tedesco TA: Red cell sorbitol: an indicator of diabetic control. Diabetes 29: 861-864,1980
33. Griffith OW: Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 107: 207-212, 1980
34. Yagi K: Assay for blood plasma or serum. Methods Enzymol 105:328-331, 1984
35. Pearse AGE: Histochemistry: Theoretical and Applied. J and A Churchill Ltd; 1968
36. Bron AJ, Sparrow J, Brown NAP, Harding JJ, Blakytny R: The lens in diabetes. Eye 7: 260-275, 1993
37. Gonzalez AM, Sochor M, Hothersall JS, McLean P: Effects of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway and glycolytic route in diabetic rat lens. Diabetes 35: 1200-1205, 1986
38. Martin PM, Roon P, VanElls TK, Ganapathy V, Smith SB: Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45: 3330-3336, 2004
39. Roufail E, Soulis T, Boel E, Cooper ME, Rees S: Depletion of nitric oxide synthase-containing neurons in the diabetic retina: Reversal by aminoguanidine. Diabetologia 42: 1228-1234, 1998
40. Mohamad S, Taha A, Bamezai RN, Basir SF, Baquer NZ: Lower doses of vanadate in combination with Trigonella restore altered carbohydrate metabolism and antioxidant status in alloxan-diabetic rats. Clin Chim Acta. 342: 105-114, 2004
41. Gonzalez AM, Sochor M, McLean P: The effect of an aldose reductase inhibitor (sorbinil) on the levels of metabolites in lenses of diabetic rats. Diabetes 32: 482-485, 1987
42. Ramasamy R, Oates PJ, Schaefer S: Aldose reductase inhibition protects diabetic and non-diabetic rat hearts from ischemic injury. Diabetes 46: 292-300, 1997
43. Takamarg Y, Kubo E, Tsuzuki S, Akagi Y: Apoptotic cell death in the lens of rat sugar cataract. Exp Eye Res 77: 51-57, 2003
44. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M: A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 52: 506-511, 2003
45. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M: Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 53: 2404-2411, 2004
46. Farkas TF, Patterson JW: Insulin and the lens. Am J Ophthalmol 44: 341-346, 1957
47. Levari R, Kirnblueth W, Wertheimer E: The effect of insulin on the uptake of monosaccharides by the rat lens. J Endocrinol 22: 361-369, 1961
48. Anuradha CV, Ravikumar P: Restoration on tissue antioxidants by fenugreek seeds (Trigonella foenum graecum) in alloxan-diabetic rats. Indian J Physiol Pharmacol 45: 408-420, 2001
49. Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ: Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 52: 864-871, 2003
50. Yoshikawa M, Murakami T, Komatsu H, Murakami N, Yamahara J, Matsuda H: Medicinal foodstuffs. IV. Fenugreek seed. (1): Structures of trigoneosides Ia, Ib, IIa, IIb, IIIa, and IIIb, new furostanol saponins from the seeds of Indian Trigonella foenum-graecum. L Chem Pharm Bull (Tokyo) 45: 81-87, 1997
51. Sauvaire Y, Petit P, Broca C, Manteghetti M, Baissac Y, Fernandez-Alvarez J, Gross R, Roye M, Leconte A, Gomis R, Ribes G: 4-Hydroxyisoleucine: A novel amino acid potentiator of insulin secretion. Diabetes 47: 206-210, 1998
52. Broca C, Gross R, Petit P, Sauvaire Y, Manteghetti M, Tournier M, Masiello P, GomEs R, Ribes G: 4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am J Physiol 227: E617-E623, 1999